The promyelocytic leukemia zinc finger (PLZF) protein exerts neuroprotective effects in neuronal cells and is dysregulated in experimental stroke

Brain Pathology

Volumn 21, Issue 1, 2011, Pages 31-43

  Seidel, Kerstin ^a   Kirsch, Sebastian ^a   Lucht, Kristin ^a   Zaade, Daniela ^a   Reinemund, Jana ^a   Schmitz, Jennifer ^a   Klare, Sabrina ^a   Li, Yaosi ^a   Schefe, Jan H ^a   Schmerbach, Kristin ^a   Goldin Lang, Petra ^a   Zollmann, Frank S ^a   Thöne Reineke, Christa ^a   Unger, Thomas ^a   Funke Kaiser, Heiko ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

(pro)renin receptor; angiotensin AT1 and AT2 receptors; experimental stroke; neuroprotection; PLZF; transcription factor

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CYCLIN A2; GLUTAMIC ACID; MESSENGER RNA; PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA ZINC FINGER PROTEIN; PROTEIN BID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; MALE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; REPORTER GENE; STROKE; UPREGULATION;

ANIMALS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CEREBRAL CORTEX; CYCLIN A2; DOWN-REGULATION; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MAGNETIC RESONANCE IMAGING; MALE; NEURONS; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ZINC FINGERS;

EID: 78649993112     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2010.00427.x     Document Type: Article

References (62)

1. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N, (2004) Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A 101: 12792-12797.
2. Barna M, Hawe N, Niswander L, Pandolfi PP, (2000) Plzf regulates limb and axial skeletal patterning. Nat Genet 25: 166-172.
3. Basic Kes V, Simundic AM, Nikolac N, Topic E, Demarin V, (2008) Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem 41: 1330-1334.
4. Brdon J, Kaiser S, Hagemann F, Zhao Y, Culman J, Gohlke P, (2007) Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke. J Hypertens 25: 187-196.
5. Brunton LL, Lazo JS, Parker KL, (2006) The Pharmacological Basis of Therapeutics, 11th edn. Goodman and Gilman's: McGraw-Hill: New York.
6. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, et al (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942.
7. Contrepas A, Walker J, Koulakoff A, Franek KJ, Qadri F, Giaume C, et al (2009) A role of the (pro)renin receptor in neuronal cell differentiation. Am J Physiol Regul Integr Comp Physiol 297: R250-R257.
8. Cook M, Gould A, Brand N, Davies J, Strutt P, Shaknovich R, et al (1995) Expression of the zinc-finger gene PLZF at rhombomere boundaries in the vertebrate hindbrain. Proc Natl Acad Sci U S A 92: 2249-2253.
9. Costoya JA, Hobbs RM, Pandolfi PP, (2008) Cyclin-dependent kinase antagonizes promyelocytic leukemia zinc-finger through phosphorylation. Oncogene 27: 3789-3796.
10. Dai WJ, Funk A, Herdegen T, Unger T, Culman J, (1999) Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30: 2391-2398. discussion 2398-2399.
11. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T, (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472.
12. De Groot CJ, Langeveld CH, Jongenelen CA, Montagne L, Van Der Valk P, Dijkstra CD, (1997) Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J Neurosci Res 49: 342-354.
13. Engelhorn T, Doerfler A, Heusch G, Schulz R, (2006) Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats. Neurosci Lett 406: 92-96.
14. Feng YH, Sun Y, Douglas JG, (2002) Gbeta gamma-independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1. Proc Natl Acad Sci U S A 99: 12049-12054.
15. Funke-Kaiser H, Bolbrinker J, Theis S, Lemmer J, Richter CM, Paul M, Orzechowski HD, (2000) Characterization of the c-specific promoter of the gene encoding human endothelin-converting enzyme-1 (ECE-1). FEBS Lett 466: 310-316.
16. Funke-Kaiser H, Lemmer J, Langsdorff CV, Thomas A, Kovacevic SD, Strasdat M, et al (2003) Endothelin-converting enzyme-1 (ECE-1) is a downstream target of the homeobox transcription factor Nkx2-5. FASEB J 17: 1487-1489.
17. Funke-Kaiser H, Reichenberger F, Kopke K, Herrmann SM, Pfeifer J, Orzechowski HD, et al (2003) Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation. Hum Mol Genet 12: 423-433.
18. Funke-Kaiser H, Reinemund J, Steckelings UM, Unger T, (2010) Adapter proteins and promoter regulation of the angiotensin AT2 receptor-implications for cardiac pathophysiology. J Renin Angiotensin Aldosterone Syst 11: 7-17.
19. Fyhrquist F, Saijonmaa O, (2008) Renin-angiotensin system revisited. J Intern Med 264: 224-236.
20. Groth W, Blume A, Gohlke P, Unger T, Culman J, (2003) Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens 21: 2175-2182.
21. Harms C, Lautenschlager M, Bergk A, Freyer D, Weih M, Dirnagl U, et al (2000) Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures. FASEB J 14: 1814-1824.
22. Hashimoto T, Yamauchi L, Hunter T, Kikkawa U, Kamada S, (2008) Possible involvement of caspase-7 in cell cycle progression at mitosis. Genes Cells 13: 609-621.
23. Hirose T, Hashimoto M, Totsune K, Metoki H, Asayama K, Kikuya M, et al (2009) Association of (pro)renin receptor gene polymorphism with blood pressure in Japanese men: the Ohasama study. Am J Hypertens 22: 294-299.
24. Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, et al (2004) Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110: 843-848.
25. Jang SW, Liu X, Fu H, Rees H, Yepes M, Levey A, Ye K, (2009) Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons. J Biol Chem 284: 24512-24525.
26. Kaschina E, Unger T, (2003) Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 12: 70-88.
27. Katchanov J, Harms C, Gertz K, Hauck L, Waeber C, Hirt L, et al (2001) Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J Neurosci 21: 5045-5053.
28. Krikov M, Thone-Reineke C, Muller S, Villringer A, Unger T, (2008) Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. J Hypertens 26: 544-552.
29. Li J, Culman J, Hortnagl H, Zhao Y, Gerova N, Timm M, et al (2005) Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 19: 617-619.
30. Li JM, Mogi M, Tsukuda K, Tomochika H, Iwanami J, Min LJ, et al (2007) Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol Endocrinol 21: 499-511.
31. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
32. Lucius R, Gallinat S, Rosenstiel P, Herdegen T, Sievers J, Unger T, (1998) The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 188: 661-670.
33. McConnell MJ, Chevallier N, Berkofsky-Fessler W, Giltnane JM, Malani RB, Staudt LM, Licht JD, (2003) Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol Cell Biol 23: 9375-9388.
34. Meffert S, Stoll M, Steckelings UM, Bottari SP, Unger T, (1996) The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol 122: 59-67. (Pubitemid 26328859)
35. Nouet S, Amzallag N, Li JM, Louis S, Seitz I, Cui TX, et al (2004) Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 279: 28989-28997.
36. Parrado A, Robledo M, Moya-Quiles MR, Marin LA, Chomienne C, Padua RA, Alvarez-Lopez MR, (2004) The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytes. Proc Natl Acad Sci U S A 101: 1898-1903.
37. Patzer A, Zhao Y, Stock I, Gohlke P, Herdegen T, Culman J, (2008) Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia. Eur J Neurosci 28: 1786-1794.
38. Paxinos G, Watson C, (1997) The Rat Brain in Stereotactic Coordinates, 3rd edn. Academic Press, Harcourt Brace & Company: London, Boston, New York, Sydney, Tokyo, Toronto.
39. Ramser J, Abidi FE, Burckle CA, Lenski C, Toriello H, Wen G, et al (2005) A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet 14: 1019-1027.
40. Rashidian J, Iyirhiaro GO, Park DS, (2007) Cell cycle machinery and stroke. Biochim Biophys Acta 1772: 484-493.
41. Rodolosse A, Barbat A, Chantret I, Lacasa M, Brot-Laroche E, Zweibaum A, Rousset M, (1998) Selecting agent hygromycin B alters expression of glucose-regulated genes in transfected Caco-2 cells. Am J Physiol 274: G931-G938.
42. Reinecke K, Lucius R, Reinecke A, Rickert U, Herdegen T, Unger T, (2003) Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J 17: 2094-2096.
43. Reinemund J, Seidel K, Steckelings UM, Zaade D, Klare S, Rompe F, et al (2009) Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes. Biochem Pharmacol 77: 1795-1805.
44. Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, Pandolfi PP, et al (2006) A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99: 1355-1366.
45. Schefe JH, Unger T, Funke-Kaiser H, (2008) PLZF and the (pro)renin receptor. J Mol Med 86: 623-627.
46. Schefe JH, Neumann C, Goebel M, Danser J, Kirsch S, Gust R, et al (2008) Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens 26: 1787-1794.
47. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, et al (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305: 245-248.
48. Schwerk C, Schulze-Osthoff K, (2003) Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem Pharmacol 66: 1453-1458.
49. Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price E Jr, Roberts RL, et al (2003) A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 22: 6471-6482.
50. Servant G, Dudley DT, Escher E, Guillemette G, (1994) The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation. Mol Pharmacol 45: 1112-1118.
51. Shiraishi K, Yamasaki K, Nanba D, Inoue H, Hanakawa Y, Shirakata Y, et al (2007) Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression. Oncogene 26: 339-348.
52. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T, (1995) The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657.
53. Stroth U, Blume A, Mielke K, Unger T, (2000) Angiotensin AT(2) receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells. Brain Res Mol Brain Res 78: 175-180.
54. Thone-Reineke C, Steckelings UM, Unger T, (2006) Angiotensin receptor blockers and cerebral protection in stroke. J Hypertens Suppl 24: S115-S121.
55. Unger T, (2005) Does losartan reduce the risk of stroke in patients with hypertension? Nat Clin Pract Cardiovasc Med 2: 236-237.
56. Uraoka M, Ikeda K, Nakagawa Y, Koide M, Akakabe Y, Nakano-Kurimoto R, et al (2009) Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin-angiotensin system. Biochem Biophys Res Commun 390: 1202-1207.
57. Wan Y, Wallinder C, Plouffe B, Beaudry H, Mahalingam AK, Wu X, et al (2004) Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 47: 5995-6008.
58. Weber MA, (1997) Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension. J Hypertens Suppl 15: S31-S36.
59. Wruck CJ, Funke-Kaiser H, Pufe T, Kusserow H, Menk M, Schefe JH, et al (2005) Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 25: 57-64.
60. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, et al (1999) Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18: 925-934.
61. Zhang J, Pratt RE, (1996) The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus. J Biol Chem 271: 15026-15033.
62. Zhang T, Xiong H, Kan LX, Zhang CK, Jiao XF, Fu G, et al (1999) Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene. Proc Natl Acad Sci U S A 96: 11422-11427.